April 7, 2022 Comments Off on New patent for Astrazeneca drug LYNPARZA Posted in: Patent Added Annual Drug Patent Expirations for LYNPARZA Lynparza is a drug marketed by Astrazeneca and is included in two NDAs. It is available from one supplier. There are eleven patents protecting…
The post New patent for Astrazeneca drug LYNPARZA appeared first…
April 7, 2022 Comments Off on Drug Patent Expirations for the Week of April 3, 2022 Posted in: Uncategorized
ORACEA (doxycycline) Galderma labs lp Patent: 9,241,946 Expiration: Apr 5, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Drug Paten…
